BeiGene, Ltd. Price (688235.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

1,361,082,567

(0.2983)%

BeiGene, Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $111.22-248
  • Market Cap 214.62B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Pharmaceuticals

  • ceo: Mr. John V. Oyler
  • IPO Date: December, 15, 2021
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 11000

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation